Some extended-release formulations of the diabetes drug metformin contained levels of a nitrosamine impurity falling above the US Food and Drug Administration’s (FDA’s) acceptable intake limit, ...
Regulators including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are looking into ...
Lupin Pharmaceuticals Inc. is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet®), 500mg, lot G901203 to the consumer level. FDA analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results